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Case Report
Abstract
This report describes a simple brachytherapy procedure in a patient with endometrial cancer with age related hyperkyphosis.
Sixty-eight year-old postmenopausal woman with age related hyperkyphosis presented with endometrial carcinoma, and the
patient was not operated on due to associated pelvic deformity. The patient received whole pelvic radiation followed by
uterovaginal brachytherapy. Patient was supported with soft pillows to support her exaggerated anterior concavity during
brachytherapy procedure and execution. The brachytherapy dose was 6 Gy per fraction per week for 3 weeks using image
guidance. This is probably the first reported case of endometrial cancer with age related hyperkyphosis. In spite of the associat-
ed skeletal problems, a simple brachytherapy procedure is possible and provides good result.
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Introduction
Endometrial cancer is the most common female genital ma-
lignancy worldwide.1 In India it is the 2nd most common
female genital tract malignancy.2 Surgery in the form of total
abdominal hysterectomy, salpingo oophorectomy with or
without pelvic lymph node dissection is the standard treat-
ment for endometrial carcinoma. Radiotherapy, either ex-
ternal or in the form of brachytherapy, is usually used in
adjuvant setting. In a selected few medically unfit patients,
who have uncontrolled diabetes, hypertension, or morbid
obesity, constituting around 10% of the cases, radical radio-
therapy can be considered. We are hereby presenting one
such case of endometrial carcinoma that could not be oper-
ated due to kyphosis, hence treated with radical radiothera-
py.
Case history
A Sixty-eight year-old postmenopausal lady with fair per-
formance status presented with history of bleeding PV of
two months duration. She was initially evaluated with a
colposcopy, which revealed an ulcerated ectocervix, histo-
pathologically consistent with chronic cervicitis. The patient
was further subjected to a dilatation and curettage; the his-
topathology was suggestive of well-differentiated adenocar-
cinoma.
The patient was further evaluated with an Magnetic Reso-
nance Imaging (MRI) of abdomen and pelvis which revealed
bulky uterus with T2 heterogeneously enhancing hyper in-
tense lesion in the endometrium measuring 48 mm × 26 mm
× 42 mm (Figure 1).
FIG.1: CT scan pelvis showing small pelvis (the transverse diameter
being 12 cm versus normal 13.5 cm).
Junction between lesion and endometrium was poorly
maintained and a lymph node measuring 12 mm in the left
parametrium was detected. There was no evidence of cervi-
cal involvement.
Subsequently a complete metastatic workup was done,
which was negative. The patient was then posted for total
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abdominal hysterectomy with bilateral salpingo-oophorect-
omy with pelvic lymph node dissection. Due to anatomical
complications, mainly age related osteoporotic hyperkypho-
sis (Figure 2) and an inaccessibly cramped pelvis, the proce-
dure could not be performed. Following this, a tumor board
meeting was conducted and a consensus for radical radiation
therapy was arrived at.
FIG 2: X ray pelvis showing associated lumbar deformity.
External beam radiotherapy
In her pre radiation assessment, the patient had hip flexion
deformity as a result of her aforementioned condition, due to
which the patient was unable to lie down in supine position
for prolonged periods of time. Pelvic immobilization was
done using aquaplast cast and knee rest. The CT based simu-
lation planning was done, with 3 mm cuts using 80 ml of
intravenous contrast. The contouring and planning were
done on Prowess Panther version 4.71 (Prowess Inc.1844
Clayton Road, Concord, California, USA). The volumes for
external radiation included the entire uterus and the vagina
as the primary volume, whereas bilateral parametrial and
pelvic lymph nodes up to the bifurcation of aorta were in-
cluded as the nodal volume.
External beam radiotherapy was delivered to a dose of 5040
cGy in 28 fractions, 5 fractions/week, using 3D-CRT tech-
nique on 6 MV linear accelerator. The treatment was deliv-
ered using 4 beams and an additional field-in-field for the
posterior beam to reduce the high dose region (Figures 3 and
4). The total monitor units (MUs) per fraction were 460. The
total treatment time including setup was approximately
10-15 minutes every day.
Brachytherapy
Following external beam radiation, the patient was planned
for high dose rate (HDR) brachytherapy. Due to the afore-
mentioned problems, we had to take additional measures to
maximize patient comfort by using soft supports for the neck
and thorax during the applicator placement, CT simulation
and also during brachytherapy execution. The CT simulation
was done with 3 mm cuts with institutional protocol of 50
ml of bladder contrast and 20 ml of rectal contrast. The
planning was done on HDR plus version 3.0.4 (Eckert &
Ziegler BEBIG GmbH, Berlin, Germany). Per American
Brachytherapy Society recommendation, High Risk Clinical
Target Volume (the target-HRCTV) included the entire
uterine wall along with the cervix and the upper third of the
vagina.3
FIG. 3: External beam radiotherapy dose distribution - Axial.
FIG. 4: External beam radiotherapy dose distribution – Sagittal.
The total volume of the HRCTV was 62.93 cc. As the
pre-treatment MRI did not show any evidence of cervical
involvement, a single uterovaginal source without ovoids
was used. The active length of the tandem was 7 cm and the
diameter of the cylinder was 3 cm. The optimization was
done at 3.2 cm at the level of tumour. At the level of bladder
and rectum, optimization was done at 2.2 cm in order to
reduce the dose to these structures. Hence, the prescribed
dose of 6 Gy covered 96.4% of the target (Figure 5) while 2
cc of bladder and rectum received 5 Gy and 2.2 Gy, respec-
tively (Figures 6 and 7). Brachytherapy was delivered using a
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remote after loading HDR unit using Co-60 source of activity
73.34 GBq, to a dose of 6 Gy/fraction prescribed to the
HRCTV (target in the Figure 8). Three such fractions were
given once per week over three weeks to a total dose of 18
Gy to the target.
FIG. 5: DVH representing 6 Gy volume coverage. [PTV for reference in yellow]
FIG. 6: DVH representing dose received by bladder 2 cc. [PTV for reference in yellow]
FIG. 7: DVH representing dose received by 2 cc of rectum. [PTV for reference in yellow]
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FIG. 8: Coronal view of target coverage (brachytherapy)
In lieu of the fixed geometry and since vaginal packing was
not done, a CT simulation was done only before the first
fraction. Subsequent fractions were delivered with the same
plan, with correction factors applied for the calculation of
the decay of the isotope in order to get accurate treatment
time.
Results and Discussion
At 6 months post treatment, the patient is on regular follow
up and there is no evidence of loco regional disease. Follow
up MRI revealed a reduction in the thickness of endome-
trium from 26 to 8 mm and complete disappearance of para-
metrial lymph node.
A pipelle aspiration on 6 months follow up was a dry tap,
suggestive of locally controlled disease.
FIG. 9: MRI pre and post RT.
Definitive radiotherapy of technically operable but medical-
ly inoperable endometrial cancer depends on the stage of the
disease. Stage I and II patients can be treated with brachy-
therapy alone. All other patients are treated with combined
external beam and brachytherapy. Since there was a pelvic
node of 1.2 cm on MRI, we treated our patient with com-
bined external radiation and brachytherapy.
With the advent of Intensity modulated radiation therapy
(IMRT) and volumetric modulated arc therapy (VMAT), it is
potentially possible to reduce the volume of normal tissues
in the irradiated field, thereby reducing the risk of acute and
chronic radiation sequelae. However, at our institution at the
time of treatment of this patient, only step and shoot IMRT
was available. The treatment time for pelvic irradiation with
step and shoot IMRT ranged from 30-45 minutes. Due to
skeletal deformity and morbid obesity, our patient was not
able to lie down in supine position for prolonged periods of
time; hence we went ahead and treated the patient with
Three Dimensional conformal radiotherapy technique
(3D-CRT).
Lin et al.4 studied the impact of body mass index (BMI) on
the systematic setup errors in patients treated with adjuvant
radiotherapy for endometrial cancer. They found that with
increasing body mass index, the systematic setup errors also
increased from 3 mm to 5.6 mm in lateral direction for nor-
mal and obese individuals respectively; 2.6 mm to 6.2 mm in
the longitudinal direction and 3 mm to 5 mm in the vertical
direction. Also, they applied the van Herk equation5 for cal-
culating margins based on BMI for normal and obese indi-
viduals. They found that for morbidly obese individuals vis a
vis normal weight individuals, the margins required were 7
mm versus 13.9 mm in the vertical; 5.3 mm versus 15.6 mm
in the longitudinal and 6.3 versus 14.9 mm in the lateral
directions. This in essence precludes the dosimetric ad-
vantages of IMRT. Hence, in a morbidly obese patient like
ours, use of IMRT may not be of much additional benefit.
Tamim et al.6 have treated 30 patients of stage I and II with
HDR brachytherapy alone to a dose of 23.9 Gy in three frac-
tions over three weeks prescribing at 2 cm from the central
axis of the tandem. A long term follow up of 15 years
showed disease specific survival (DSS) of 91% and 42 % for
stage I and II respectively.
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Nguyen et al.7 have treated 36 similar patients with a dose of
45 Gy in five weekly fractions and they observed three year
DSS of 85%. They also noted that the late rectal and bowel
complications were seen in 21% of patients and attributed it
to the higher dose that was used. A case controlled study by
Peter et al.8 of Stage I and II patients treated by primary ra-
diation therapy matched to surgically treated controls
showed no statistical difference in survival.
Churn et al.9 have treated 37 patients with a combination of
external beam radiotherapy and intracavitary brachytherapy
using a single line source technique and observed a 5-year
disease-specific survival of 68.4% for Stages I and II and
33.3% for Stages III and IV. The important factor was that,
each patient’s dose prescription points were based not only
on the length, but also on the bulk of the disease and indi-
vidual anatomy.
Age-related postural hyperkyphosis is an exaggerated anteri-
or curvature of the thoracic spine, sometimes referred to as
Dowager’s hump or gibbous deformity. This condition im-
pairs mobility, and increases the risk of falls and fractures. As
kyphosis increases, there are concomitant alterations in the
normal sagittal plane alignment like flexion deformity of the
pelvic girdle.10 To our knowledge, our patient is the first
reported case of age related osteoporotic hyper kyphosis with
fixed flexion deformity of the pelvis making the patient in-
operable.
Historically brachytherapy for inoperable cancer endome-
trium has been carried out with various techniques such as
Heyman’s capsule, a rigid tandem, a biconcave butterfly ap-
plicator or even a regular intracavitary application prescrib-
ing to point A. Each of these has its own advantages and
limitations.11 An ideal applicator for inoperable endometrial
cancer, consists of dual tandem placed in each cornu of the
uterus, which provides optimal distribution at the fundus.3
Due to non-availability of the dual tandem, we used single
uterovaginal source and since the locoregional recurrence
following surgery for endometrial cancer is around 14% and
two thirds of these are seen in the vagina12 the upper part of
the vagina was also treated.
The advantage of single uterovaginal source is that the pro-
cedure can be simple and completed fast, especially in pa-
tients like ours, who are unable to lie supine for long periods
of time due to pelvic deformity.
Follow up includes MRI based assessment as well as check
curettage. Follow up MRI at 6 months of treatment revealed
a good regression of the disease, a reduction in endometrial
thickness down to 8 mm compared to 26 mm before treat-
ment and a complete resolution in the size of the pelvic
lymphnode. Rose et al.13 have performed a D & C at 6
months of radiotherapy and residual disease was seen in 2/27
patients. However, the study period was 1974-1992 and
probably an MRI in the present time would have been an
ideal follow-up investigation.
We subjected our patient to pipelle aspiration which turned
out to be dry and hence a regular follow up is planned.
A Pipelle is a plastic flexible tube with a piston inside and
works on the principle of suction. It can be inserted into the
uterine canal without any dilatation and hence can be done
along with routine gynecological examination. In a study by
Ibrahim et al.14, pipelle was followed by routine D and C in
patients with abnormal uterine bleeding and the results were
compared .The sample obtained was adequate in 97.9% of
patients and opined that it can replace conventional D and C
in patients who have an endometrial thickness of more than
5 mm. They also noticed 100% sensitivity, specificity and
predictive value for both endometrial hyperplasia as well as
for endometrial cancer.
Limitation
An MRI scan post external radiotherapy would have pro-
vided the differential quantification of disease response after
external radiation alone when compared with external radia-
tion plus brachytherapy.
Conclusion
For medically inoperable endometrial cancer patients, defin-
itive radiation therapy is a viable alternative. Single
uterovaginal brachytherapy technique not only delivers the
required dose to the disease, but also is easy for patients who
cannot lie in supine position for prolonged periods of time
due to skeletal deformity.
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